News | April 28, 2022
Cipla bags Pharma Leader of the Year award
Glenmark Pharmaceuticals won Innovation of the Year award
Glenmark Pharmaceuticals won Innovation of the Year award
The summit also saw the launch of two important reports- Multi-Regional Clinical Trials (MRCT) and Value of OTC in India
Feedback and remarks of the industry and stakeholders are invited till the 25th of March 2022
A total of 49 projects have been approved so far for 33 critical APIs with a committed investment of Rs 3,685 crore
Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers releases guidelines for the scheme
The aim is to strengthen industry-academia cooperation
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
Availability of drugs is being monitored by implementing a three-pronged strategy of supply chain management, demand side management, and affordability.
Integration of various regulatory agencies with a single-window system and putting in place a transparent, stable, predictable and easy to navigate interface.
The company received approval for 2-Methyl-5Nitro-Imidazole (2-MNI) with a committed production capacity of 4,000 MT per annum.
Subscribe To Our Newsletter & Stay Updated
